ColoSTEM Dx Kit: Innovative Alliance of Cancer Stem Cells and Glycosylation for Earlier Prediction of Colon Cancer Aggressiveness and Prognosis
Sabrina Blondy(Raptamer Discovery Group (United States)), Muriel Mathonnet(Inserm)
Cited by 1
Related Papers
5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
|Cancer Science|2020|477
European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma
|British journal of surgery|2017|220
Pharmacological targeting of the protein synthesis mTOR/4E‐BP1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistance
|EMBO Molecular Medicine|2015|196
FAK activity in cancer‐associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer
|EMBO Molecular Medicine|2020|105